Trial Profile
Phase IIa trial of FP 01-Immune Targeting Systems (Flunisyn) in elderly patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2013
Price :
$35
*
At a glance
- Drugs FP 01-Immune Targeting Systems (Primary) ; Influenza virus vaccine
- Indications Influenza A virus infections; Influenza virus infections
- Focus Therapeutic Use
- 18 Apr 2013 Positive results were presented at World Vaccine Congress, according to an Immune Targeting Systems media release.
- 18 Apr 2013 New trial record